<< Read Full Article
<< Read Full Article
ImClone's Profits Decline
- Loading Comments...
ImClone System's(IMCL Quote) quarterly earnings beat analysts' expectations Tuesday but fell year over year, as did U.S. sales of its cancer drug Erbitux.
ImClone reported earnings of $31.9 million, or 36 cents a share, compared with $37.2 million, or 42 cents a share, in the same period in 2006. Analysts surveyed by Thomson Financial were expecting 30 cents a share for the quarter.
ImClone said its total revenue was $150.5 million, compared with $149.9 million in the year-ago quarter. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,453.06 | 1,107.47 | 2,171.10 | 32.40 |
Oil *
79.60
|
|
UP
108.22
|
UP
11.84
|
UP
26.50
|
UP
0.39
|
10 Yr
3.24%
SPDR Gold
117.20
|
|
+1.05%
|
+1.08%
|
+1.24%
|
+1.22%
|
Data delayed 20 minutes |


Connect with TheStreet